A detailed history of Syntax Research, Inc. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 142 shares of LXRX stock, worth $139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142
Previous 142 -0.0%
Holding current value
$139
Previous $341,000 29.91%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.06 - $2.33 $150 - $330
142 New
142 $155,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $185M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Syntax Research, Inc. Portfolio

Follow Syntax Research, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Research, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Syntax Research, Inc. with notifications on news.